Abstract
Since most of the pathogenic microbes have developed resistance against chemical drug derivatives therefore need of the hour is to formulate plant based natural medicines. These formulations with no or least toxicity can prove better alternative of synthetic drugs. Ethnopharmacologists, botanists, microbiologists, and natural-products chemists are combing the earth for phytochemicals and “leads” which could be developed for the treatment of infectious diseases. While, 25 to 50% of current pharmaceuticals are derived from plants, none are used as antimicrobials. Traditional healers have long used plants to prevent or cure infectious conditions; western medicine is trying to duplicate their successes. Plants are rich in a wide variety of secondary metabolites, such as tannins, terpenoids, alkaloids, and flavonoids, which have been found in vitro to have antimicrobial properties. The present review mainly discusses exploitation of plant secondary compounds as antimicrobial agents. Mode of action of some agents was also addressed. Since many of these compounds are currently available as unregulated botanical preparations and their use by the public is increasing rapidly, clinicians need to consider the consequences of patients self-medicating with these preparations.
Keywords: Natural Drugs, Secondary metabolites, Antimicrobial agents, Botanical preparations, Pharmaceuticals, Plant, Natural product, Phytochemicals, Microbiologists, Synthetic drugs
The Natural Products Journal
Title: Antimicrobial Potential of Botanicals and Disease Control
Volume: 1 Issue: 2
Author(s): Madhu Rathore, Kanika Sharma and Naveen Sharma
Affiliation:
Keywords: Natural Drugs, Secondary metabolites, Antimicrobial agents, Botanical preparations, Pharmaceuticals, Plant, Natural product, Phytochemicals, Microbiologists, Synthetic drugs
Abstract: Since most of the pathogenic microbes have developed resistance against chemical drug derivatives therefore need of the hour is to formulate plant based natural medicines. These formulations with no or least toxicity can prove better alternative of synthetic drugs. Ethnopharmacologists, botanists, microbiologists, and natural-products chemists are combing the earth for phytochemicals and “leads” which could be developed for the treatment of infectious diseases. While, 25 to 50% of current pharmaceuticals are derived from plants, none are used as antimicrobials. Traditional healers have long used plants to prevent or cure infectious conditions; western medicine is trying to duplicate their successes. Plants are rich in a wide variety of secondary metabolites, such as tannins, terpenoids, alkaloids, and flavonoids, which have been found in vitro to have antimicrobial properties. The present review mainly discusses exploitation of plant secondary compounds as antimicrobial agents. Mode of action of some agents was also addressed. Since many of these compounds are currently available as unregulated botanical preparations and their use by the public is increasing rapidly, clinicians need to consider the consequences of patients self-medicating with these preparations.
Export Options
About this article
Cite this article as:
Rathore Madhu, Sharma Kanika and Sharma Naveen, Antimicrobial Potential of Botanicals and Disease Control, The Natural Products Journal 2011; 1 (2) . https://dx.doi.org/10.2174/2210315511101020105
DOI https://dx.doi.org/10.2174/2210315511101020105 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |
Call for Papers in Thematic Issues
Ayurvedic medicinal therapeutic approaches for inflammatory and neurodegenerative disorders
Usually, in our elderly population, neurodegenerative disorders occur due to neuron death. Alzheimer?s disease (AD) is an irreversible and progressive neurodegenerative disease. Dementia is the leading cause of AD, which affects about 30 million people worldwide. According to the World Alzheimer report 2018, a new case of dementia develops every ...read more
Recent Advances in Biotransformation of Bioactive Terpenoids using Aspergillus niger
Biotransformation is the reaction catalyzed by biological catalysts of either isolated enzymes or whole cell cultures of microorganisms. This process has been extensively applied in the conversion of bioactive terpenoids with high regio- and stereospecifity. This process has been also applied in the lead discovery and development. Aspergillus niger has ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Anti-malarial Drug Artesunate Blocks Wnt/β-catenin Pathway and Inhibits Growth, Migration and Invasion of Uveal Melanoma Cells
Current Cancer Drug Targets CD24, A Review of its Role in Tumor Diagnosis, Progression and Therapy
Current Gene Therapy Liver Tolerance and the Manipulation of Immune Outcomes
Inflammation & Allergy - Drug Targets (Discontinued) Electroporation Gene Therapy Preclinical and Clinical Trials for Melanoma
Current Gene Therapy Curcumin Efficacy in a Serum/Glucose Deprivation-Induced Neuronal PC12 Injury Model
Current Molecular Pharmacology Primary and Secondary Prevention Trials in Alzheimer Disease: Looking Back, Moving Forward
Current Alzheimer Research A Review of Therapeutic Effects of Curcumin
Current Pharmaceutical Design Protein Tyrosine Phosphatases, New Targets for Cancer Therapy
Current Cancer Drug Targets To Die or Not to Die: That is the Autophagic Question
Current Molecular Medicine Consequences of Iron Accumulation in Microglia and its Implications in Neuropathological Conditions
CNS & Neurological Disorders - Drug Targets Targeting Conserved Pathways: Mitochondrial Dysfunction and Beyond
Current Neurovascular Research Oxadiazole Derivatives as Anticancer and Immunomodulatory Agents: A Systematic Review
Current Medicinal Chemistry Update on the Use of Biologics in Vasculitides
Current Pharmaceutical Biotechnology Neurotoxicity of Ecstasy (MDMA): An Overview
Current Pharmaceutical Biotechnology Multiple Functions of Generic Drugs: Future Perspectives of Aureolic Acid Group of Anti-Cancer Antibiotics and Non-Steroidal Anti-Inflammatory Drugs
Mini-Reviews in Medicinal Chemistry Targeting the Cholinergic System for Neuroprotection and/or Enhancement of Functional Recovery Following Neurotrauma
Current Pharmaceutical Design Prospects and Limitations of T Cell Receptor Gene Therapy
Current Gene Therapy Immunohistochemical Expression of Vascular Endothelial Growth Factor (VEGF) and its Possible Role in Tumour Progression During Malignant Transformation of Atrophic Epithelium in Oral Submucous Fibrosis
Current Angiogenesis (Discontinued) Interaction of Autophagy and Toll-Like Receptors: A Regulatory Cross- Talk - Even in Cancer Cells?
Current Drug Targets Peptide Based Vaccine Design for Cancer Immunotherapy
Letters in Drug Design & Discovery